- Intense cost-competitive generic drug market.
- Stricter regulations on drug inspections, registration, and patents.
- Competition for biotech talents.
- Reliance on imported raw materials.
- Mergers and acquisitions by large biotech companies.
- Lower budgetary support for healthcare in various countries.
YungShin Global Holding Corporation
Greenhouse gas emissions & sustainability report data
In its 2023 reporting, YungShin Global Holding Corporation disclosed greenhouse gas emissions of 6.5K tCO2e (2022); Data for 2023 still being compiled. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
6.5K tCO2e (2022); Data for 2023 still being compiled
2023
Water Usage
116.08 mL (2022); Data for 2023 still being compiled
2023
Waste
122.4K tons (2022); Data for 2023 still being compiled
2023
📈 Emissions by Report Period
| Report period | Headline emissions figure reported |
|---|---|
| 2023 | 6.5K tCO2e (2022); Data for 2023 still being compiled |
| 2022 | 740 tons/year reduction (from boiler fuel change) |
Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.
✅ Reported Environmental Achievements
- Reduced carbon emissions by approximately 740 tons per year through boiler fuel conversion.
- Saved 44,358 kWh/year in electricity, reducing carbon emissions by 22.275 tons/year through LED lamp replacements.
- Recycled water reuse reached 11,000 tons in 2023 at the injection plant.
🎯 Climate & Sustainability Targets
🔜 Short-term
- Gradually complete the greenhouse gas inventory for the company and its consolidated subsidiaries by 2025.
🔭 Long-term
- Expand into Europe, South America, Africa, and other emerging markets.
🌱 ESG Focus Areas
EnvironmentalSocialGovernance